This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $5,730.00. It was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $2,866.50, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply product. The contract is a Delivery Order type with a Firm Fixed Price pricing arrangement, and has an ultimate completion date of June 11, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, which...
This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award is for the delivery of Multihance 529 mg/ml vial, 10 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, with a GovTribe ID of SPE2DX15D6028|SPE2DX25FWLUQ, was issued by the Defense Logistics Agency's Medical Supply Chain division to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,680.18 firm-fixed-price delivery order is for the supply of MULTIHANCE 529MG/ML 5S, a pharmaceutical product. The contract has an ultimate completion date of June 10, 2025 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Multihance 529mg/ml. The delivery order, valued at $5,323.05, has a firm fixed price and an ultimate completion date of March 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a potential value of $1,719.90 and a completion date of January 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has a history of providing pharmaceutical products and medical supplies to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, to provide MULTIHANCE 529 MG/ML VIAL 20ML, a specialty pharmaceutical product. The delivery order has a ceiling value of $1,189.20 and a period of performance through April 5, 2024. This award is a child contract under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, also awarded by DLA, with a potential...
This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...